Drug
epcoritamab-bysp
Marketed as EPKINLY.
Generic name
epcoritamab-bysp
Brand names
EPKINLY
First FDA approval
2023-05-19
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761324 | EPKINLY | 2023-05-19 | GENMAB US, INC. |
Manufacturers
GENMAB US, INC.
Frequently asked questions
When was epcoritamab-bysp FDA approved?
Earliest FDA approval on record: 2023-05-19.
What brand names are sold as epcoritamab-bysp?
EPKINLY.
Sources
Appeal a epcoritamab-bysp denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com